Taxas, USA (CU)_ A new Yale Cancer Center paper outlines the latest innovative medicines and treatments for non-small cell lung cancer (NSCLC). The study’s purpose is to provide insight into how developments in basic science will reflect on clinical research areas, with the goal of studying how NSCLC could be handled in the following decade. The article was recently published in the journal Nature Medicine.
Meina Wang, PhD, Yale Cancer Center’s associate research scientist and chief author of the perspective, spoke about cancer treatment worldwide. She said…
